Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.
Finckh A, Ciurea A, Brulhart L, Kyburz D, Möller B, Dehler S, Revaz S, Dudler J, Gabay C; Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis. Finckh A, et al. Among authors: moller b. Arthritis Rheum. 2007 May;56(5):1417-23. doi: 10.1002/art.22520. Arthritis Rheum. 2007. PMID: 17469098 Free article.
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C; Arthritis. Finckh A, et al. Among authors: moller b. Ann Rheum Dis. 2010 Feb;69(2):387-93. doi: 10.1136/ard.2008.105064. Epub 2009 May 4. Ann Rheum Dis. 2010. PMID: 19416802 Free PMC article.
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.
Alpizar-Rodriguez D, Brulhart L, Mueller RB, Möller B, Dudler J, Ciurea A, Walker UA, Von Mühlenen I, Kyburz D, Zufferey P, Mahler M, Bas S, Gascon D, Lamacchia C, Roux-Lombard P, Lauper K, Nissen MJ, Courvoisier DS, Gabay C, Finckh A. Alpizar-Rodriguez D, et al. Among authors: moller b. Clin Rheumatol. 2017 Mar;36(3):677-682. doi: 10.1007/s10067-017-3547-3. Epub 2017 Jan 21. Clin Rheumatol. 2017. PMID: 28110385 Free article.
Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.
Stekhoven D, Scherer A, Nissen MJ, Grobéty V, Yawalkar N, Villiger PM, Möller B; Swiss Clinical Quality Management for Rheumatic Diseases. Stekhoven D, et al. Among authors: moller b. Clin Rheumatol. 2017 Sep;36(9):2035-2043. doi: 10.1007/s10067-017-3637-2. Epub 2017 Apr 22. Clin Rheumatol. 2017. PMID: 28432523 Free PMC article.
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
Micheroli R, Hebeisen M, Wildi LM, Exer P, Tamborrini G, Bernhard J, Möller B, Zufferey P, Nissen MJ, Scherer A, Ciurea A; Rheumatologists of the Swiss Clinical Quality Management Program. Micheroli R, et al. Among authors: moller b. Arthritis Res Ther. 2017 Jul 19;19(1):164. doi: 10.1186/s13075-017-1372-3. Arthritis Res Ther. 2017. PMID: 28724442 Free PMC article.
1,168 results